The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Asthma News
Asthma News - October 9, 2025
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails at MDHHS-Asthma@michigan.gov.
Children’s Hospital of Philadelphia (CAPP) Webinar:17th Annual Fighting Asthma Disparities Summit ~ Oct. 21 @ 8:30-4:30 PM EDT
Attendees will have opportunities to learn about the impact of social determinates of health on asthma prevalence and morbidity, early-life predictors of asthma development, and advocating for asthma inhaler medication. Free!
Extent of Cannabis Use, State Laws/Policies, Potential Harms, Guidelines for Use ~ Oct. 23 @ 1 PM ET
This webinar will explore the current policy landscape of cannabis use across the country, highlighting laws and regulations for medical and non-medical consumption and their public health implications. Speakers will also discuss emerging research on the latest trends, potential risks, and harms, with a focus on adolescent use.
MI Quitlink: FREE Tobacco Cessation Provider Toolkits Available
Get the tobacco cessation materials you need to help your patients quit, delivered directly to your clinic. The toolkit includes: Quit Smoking Guide Tear Off Pad (50 sheets), Quit Smoking Medication Cards (10 cards), Quit Smoking Clinic Posters (10 posters), Quitlink Pocket Cards (50 cards) and additional provider resources.
CHEST: Biologic Management in Severe Asthma for Adults: An American College of Chest Physician Clinical Practice Guideline
A systematic review and critical analysis of the literature on the seven PICO (population, intervention, comparator, and outcome) questions related to choice of biologic agent in severe asthma patients resulted in seven evidence-based recommendations.
Menopause is not associated with asthma or severe asthma
Among women who never used oral contraceptives or female hormone therapy, no significant link was found between menopause and the odds for asthma. Age also confounded the link between menopause and asthma.
The dose-response of inhaled corticosteroids (ICS) in combination ICS/long-acting beta2-agonist (LABA) maintenance therapy for asthma: a systematic review and meta-analysis
Maintenance high-dose ICS/LABA reduces the odds of a severe exacerbation by about 20% compared to medium-dose ICS/LABA. The absolute reduction in severe exacerbation risk with high-dose ICS/LABA is determined by patients’ exacerbation risk, and this effect size may be clinically relevant for patients if this risk is high.